Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Infectious Agents and Cancer

Infectious Agents and Cancer

Infectious Agents and Cancer

Editor-in-Chief: F.M. Buonaguro; S.M. Mbulaiteye
Managing Editor: Maria Lina Tornesello

ISSN: 1750-9378 (electronic version)

Journal no. 13027

BioMed Central

Open access BioMed Central
  • ·         Publishing insights on the association between chronic infections and cancer
  • ·         Internationally renowned Editorial Board
  • ·         Affiliated with the African Organisation for Research & Training In Cancer (AORTIC)

Infectious Agents and Cancer is an open access journal dedicated to publishing insights on the association between chronic infections and cancer. The journal’s scope covers all areas of biomedical research related to the development of preventive strategies, innovative diagnostic and biomolecular methodologies and promising therapeutic strategies for treating chronic infections and cancer. Infectious Agents and Cancer aims to serve as an international platform to showcase research and resources for cancer prevention, diagnosis, treatment and palliative care.

Related subjects » Cancer Research - Internal Medicine - Oncology & Hematology

Impact Factor: 1.422 (2016) * 

Journal Citation Reports®

Abstracted/Indexed in 

PubMedCentral, SCOPUS, Google Scholar, CAB International, Academic OneFile, CAB Abstracts, CNKI, Current Abstracts, EBSCO Academic Search, EBSCO Biomedical Reference Collection, EBSCO CINAHL, EBSCO STM Source, EBSCO TOC Premier, Global Health, Health Reference Center Academic, OCLC, SCImago, Summon by ProQuest

Read This journal on BioMed Central

For authors and editors

  • Journal Citation Reports®
    2016 Impact Factor
  • 1.422
  • Aims and Scope

    Aims and Scope


    Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.

    The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:

    • HPV and anogenital cancers, as well as head and neck cancers;
    • EBV and Burkitt lymphoma;
    • HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;
    • HHV8 and Kaposi sarcoma;
    • HTLV and leukemia;
    • Cancers in Low- and Middle-income countries.

    The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.

    Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.

    Moreover “omics” is contributing to and accelerating the discovery not only of novel pathogens, but of genetic predisposition as the genetic make-up of organisms and individuals is unraveled. The hunt for molecular signatures of cancer causation, early cancer, or cancer Achilles heels promises new ways to practice precision medicine and public health. The explosion of knowledge in tumor genomics, tumor biology, targeted therapies, gene-environment interactions, immunology and immunotherapy needs a space for robust and vigorous debate.

    Infectious Agents and Cancer covers all these areas of biomedical research and any other topics pertinent to the development of preventive strategies, innovative diagnostic and biomolecular methodologies, promising therapeutic strategies for chronic infections and cancer. Immunotherapeutic strategies will include: profiling and activation of dendritic cells; reactivation of the immune system; breaking immune tolerance; modulation of the immune system by cytokines and drug delivery systems.

  • Submit Online
  • English Language Editing

    English Language Editing


  • Writing Resources: Training for Authors